Clinical Trial Update: Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia

View source ↗

Summary

This item reports a completed clinical trial evaluating the impact of Optical Genome Mapping in acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Acute Myeloblastic Leukemia | Status: COMPLETED